✦ LIBER ✦

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

✍ Scribed by Antoine Hadengue; Adrián Gadano; Moreau Richard; Emile Giostra; François Durand; Dominique Valla; Serge Erlinger; Didier Lebrec

Book ID: 118567924
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 100 KB
Volume: 29
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80151-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Albumin improves the beneficial effects

Albumin improves the beneficial effects of terlipressin in hepatorenal syndrome

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Study of terlipressin administration wit

Study of terlipressin administration with and without albumin in hepatorenal syndrome (HRS)

✍ Abulfutuh, Ashraf R.; Morsy, Mohammed; Solyman, Abd El Ghany; Hendawy, Said El; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Predictors of response to therapy with t

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

✍ André Nazar; Gustavo Henrique Pereira; Mónica Guevara; Marta Martín-Llahi; Marie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T

[82] RANDOMIZED, COMPARATIVE STUDY OF TE

[82] RANDOMIZED, COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN VS ALBUMIN ALONE IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME

✍ M. Martin-Llahi; M.N. Pepin; M. Guevara; A. Torre; A. Monescillo; G. Soriano; F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Effects of terlipressin administration w

Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II study

✍ R. Ortega; P. Gines; J. Uriz; B. Calahorra; A. Cardenas; D. De Las Heras; M. Gue 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Pathogenesis and management of hepatoren

Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis

✍ Paolo Angeli; Carlo Merkel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 303 KB